J9072 Injection cyclophos frindovyx 5 milligrams
Also known as: cyclophosphamide, Frindovyx
Intravenous injection of cyclophosphamide (Frindovyx brand), an alkylating agent chemotherapy, dosed at 5 milligrams.
In Plain Language
DNA-damaging alkylating cancer drug; immune-suppressing chemotherapy
Clinical Context
Brand-specific formulation of cyclophosphamide for cancer and autoimmune disorder treatment.
RVU Information
CPT J9072 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.
Specialties
Frequently Asked Questions
What is CPT code J9072?
CPT J9072 (Injection cyclophos frindovyx 5 milligrams) is a J Codes (Drugs) code. Intravenous injection of cyclophosphamide (Frindovyx brand), an alkylating agent chemotherapy, dosed at 5 milligrams.
How is J9072 administered?
CPT J9072 is administered by a healthcare provider, typically via injection or infusion. Brand-specific formulation of cyclophosphamide for cancer and autoimmune disorder treatment. It is used by Oncology, Medical Oncology.
When is CPT J9072 used?
Brand-specific formulation of cyclophosphamide for cancer and autoimmune disorder treatment.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.